Relationship of symptomatology of schizophrenia and tardive dyskinesia.
The role of drug factors and patient factors in the development of tardive dyskinesia (TD) was examined in 31 TD patients and 31 non-TD patients matched by age and sex. TD patients achieved significantly lower total scores on the anxiety-depression factor of Brief Psychiatric Rating Scale (BPRS) (5.2 +/- 1.4 vs. 6.5 +/- 2.2; less than P) and significantly higher total scores on the activation factor (6.4 +/- 2.2 vs. 5.3 +/- 2.5; less than P). The finding that TD patients were less depressed may be explained by a hypermonoaminergic state developing in TD. Based on the findings of this study it is suggested that catatonic schizophrenic patients are more vulnerable to the development of TD.
Perenyi
A
A
National Institute for Nervous and Mental Diseases, Budapest, Hungary.
Norman
T
T
Burrows
G D
GD
D000293:Adolescent; D000328:Adult; D015306:Biogenic Monoamines / Q000097:blood; D003863:Depression / Q000150:complications / Q000523:psychology; D004409:Dyskinesia, Drug-Induced / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000150:complications*; D012565:Schizophrenic Psychology
D015306:Biogenic Monoamines